RSV hospitalization in cystic fibrosis in the Canadian registry of palivizumab (CARESS) following prophylaxis (2005-2012)

I. Mitchell, B. Paes, A. Li, K. Lanctot (Calgary, Hamilton, Toronto, Canada)

Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Session: Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Session type: Poster Discussion
Number: 3612
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Mitchell, B. Paes, A. Li, K. Lanctot (Calgary, Hamilton, Toronto, Canada). RSV hospitalization in cystic fibrosis in the Canadian registry of palivizumab (CARESS) following prophylaxis (2005-2012). Eur Respir J 2013; 42: Suppl. 57, 3612

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
RSV hospitalization in infants with neuromuscular disease in the Canadian registry of palivizumab after prophylaxis (2005-2012)
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013


Respiratory syncytial virus (RSV) hospitalization in infants with congenital airway anomalies (CAA) in the canadian registry of palivizumab (CARESS) after prophylaxis (2005-2012)
Source: International Congress 2014 – Paediatric epidemiology: new insights into primary ciliary dyskinesia, prematurity and bronchiolitis
Year: 2014

RSV hospitalization in Down syndrome in the Canadian Registry of Synagis (CARESS) following prophylaxis (2006-2011)
Source: Annual Congress 2012 - New insights into respiratory infections in children
Year: 2012

Respiratory related hospitalizations in premature infants prophylaxed with palivizumab In the Canadian registry of palivizumab (CARESS)
Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma
Year: 2015


Risk factors that determine time to first RSV hospitalization in CARESS: The Canadian registry of palivizumab (2005-2011)
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012

Factors associated with compliance with palivizumab treatment in the Canadian rSV evaluation study for synagis (CARESS) registry (32005-2011)
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012

Underlying clinical conditions and invasive pneumococcal disease (IPD) in adults in Spain (ODIN study, 2010-2012)
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013



Incidence and outcomes of hospitalized for COPD exacerbations with and without pneumonia, 2006-2012: A nationwide cohort study
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

CARESS: The Canadian registry of palivizumab (2005-2010)
Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae
Year: 2011


Hospitalization, mortality and vaccine effectiveness in a group of chronic obstructive pulmonary disease (COPD) patients during influenza season 1999 - 2000
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001

The burden of hospitalized all-cause and pneumococcal pneumonia in Spain (2010)
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Cryptogenic organizing pneumonia in Spain. Study of 309 patients (1985-2002)
Source: Eur Respir J 2004; 24: Suppl. 48, 535s
Year: 2004

Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015


Observation of pregnant women (PW) after severe pneumonia (P) with influenza A/H1N1 virus infection in 2009-2010: Long-term results
Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic
Year: 2011

Influence of comorbidities in the clinical presentation of invasive pneumococcal disease (IPD) in adults in Spain, 2010-2013. The ODIN study
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Clinical cure rates in patients treated with azithromycin (AZ) for lower respiratory infections (LRTI) caused by AZ-susceptible (AZ-S) and AZ-resistant (AZ-R) organisms: Analysis of phase 3 clinical trials
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014


Risk of hospitalization due to pneumococcal pneumonia in adults in Spain. The CORIENNE study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Increasing prevalence of complicated pneumonia and pneumococcal related hemolytic uremic syndrome despite territory-wide program of pneumococcal conjugated vaccination (PCV-7) program in children
Source: International Congress 2014 – Paediatric epidemiology: wheeze, asthma and other respiratory diseases
Year: 2014

Incidence of hospitalized all-cause pneumonia, and serotype distribution of hospitalized streptococcus pneumoniae pneumonia in Norway 2008-2009
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Flu A(H1N1pdm09) and pneumonia: the burden of comorbidities (2009 vs 2019)
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019